China Hemodialysis Industry Research Report 2011-2020 - Foreign Capital Brands Accounted for 80% of the Market Share in 2015 - Research and Markets

DUBLIN, June 13, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Research Report on Hemodialysis Industry in China, 2011-2020" report to their offering.

With the improvement of Chinese medical care as well as the increasing income and payment ability of hemodialysis patients, the hemodialysis industry will develop rapidly in the future. Hemodialysis services mainly consist of dialyzers, dialysis consumables, dialysis drugs and labor services. Hemodialysis instruments include dialysis machines, dialyzers and dialysis pipelines. Dialyzers are core consumables with high technical barriers, which accounts for the largest market share. The market size in China exceeded CNY 5 billion while the domestic market share was approximately 30% in 2015.

The market size of China's dialysis machines reached about CNY 3 billion in 2015, and the foreign capital brands accounted for 80% of the market share. The hemodialysis powder and fluid are important solvents in the process of hemodialysis. In spite of relatively low technical barriers, domestic enterprises account for over 90% of the market share thanks to the high transport cost (The reasonable transportation radius is no larger than 800 km) and policy barriers. In addition, the market competition is not fierce. Conventional hemodialysis medicines include EPO and heparin which are in general domestically produced. Service costs include costs of bed and health care labors.

Presently, the average hemodialysis expense is about 400-500 CNY for each treatment in China. The gross profit rate of the hemodialysis business can universally reach 30-40% or higher. Charges in public hospitals are generally higher than those of private hospitals, of which the gross profits can reach above 50%. According to the author there were about 4,000 hemodialysis centers in China up to the end of 2015.

In 2015, the hemodialysis market size exceeded CNY 20 billion with an increase of more than 15% in recent years. The global ESRD patients received hemodialysis treatment estimated to reach 4 million, and those in China will surpass 600,000 accounting for 15%. It is predicted that the overall market size of the hemodialysis industry will increase to over CNY 50 billion by 2020.

Key Topics Covered:

1 Related Concepts of Hemodialysis Industry

2 Analysis and Forecast of Global Hemodialysis Market

3 Development Environment of Hemodialysis Industry in China, 2011-2020

4 Operation Status of Hemodialysis Industry in China, 2011-2015

5 Competition Status of Hemodialysis Industry in China, 2011-2016

6 Analysis on Import and Export of Hemodialysis Equipment and Drugs in China, 2011-2015

7 Key Enterprises in Hemodialysis industry, 2011-2016

8 Prospect of Hemodialysis Industry in China, 2016-2020

Companies Mentioned

- Asahi Kasei Medical Co., Ltd.
- Bain Medical Equipment (Guangzhou) Co., Ltd.
- Baxter International Inc.
- Fresenius Medical Care
- Guangdong Biolight Meditech Co., Ltd.
- Jihua Medical Apparatus & Instruments Co., Ltd. Guangzhou
- NIPRO Medical Corporation
- SWS Hemodialysis Care Co., Ltd.
- Shandong Weigao Group Medical Polymer Co., Ltd.
- Sichuan Kelun Pharamceutical Co., Ltd.
- Zhuhai Hokai Medical Instruments Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/zvst7h/research_report

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]